AI & Tech Newsai machine learningai technologyai-techpark newsArtificial Intelligencecyber security companiescyber security informationcyber threatsMachine LearningTevogen
Tevogen Expands PredicTcell Data 100x to Boost T Cell Therapies
Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced significant progress in the development of its proprietary PredicTcell™ platform, designed to accelerate precision immunotherapy development and efficacy through advanced machine learning and transformer-based models. The platform is being developed with the support of Microsoft (Nasdaq: MSFT) and Databricks, leveraging their advanced...
The post Tevogen Expands PredicTcell Data 100x to Boost T Cell Therapies first appeared on AI-Tech Park.